Femoxetine in the treatment of patients with depressive illness–a randomized comparison with amitriptyline
- 1 January 1982
- journal article
- research article
- Published by Taylor & Francis in Nordisk Psykiatrisk Tidsskrift
- Vol. 36 (6) , 329-333
- https://doi.org/10.3109/08039488209102166
Abstract
The significance of the antidepressants' serotonin-potentiating properties in relationship to the therapeutic effect has been one of the key research areas within depression during the last decades. On this basis a number of drugs with more selective influence on the serotonin system has been developed and the following study is a controlled clinical evaluation of femoxetine, a phenylpiperidine derivative with potent serotonin-potentiating properties in patients suffering from a depressive illness.Keywords
This publication has 11 references indexed in Scilit:
- Changes in platelet function and blood serotonin level in migraine patients during treatment with femoxetineActa Neurologica Scandinavica, 1982
- Antidepressant effect of femoxetine and desipramine and relationship to the concentration of amine metabolites in cerebrospinal fluidActa Psychiatrica Scandinavica, 1982
- Fluvoxamine and clomipramine in depressed patients A DOUBLE‐BLIND CLINICAL STUDYActa Psychiatrica Scandinavica, 1981
- The Hamilton Depression ScaleActa Psychiatrica Scandinavica, 1981
- ‘A double-blind study of femoxetine and amitriptyline in patients with endogenous depression’Nordisk Psykiatrisk Tidsskrift, 1979
- Antidepressant evaluation and the pharmacological actions of FG4963 in depressive patientsEuropean Journal of Pharmacology, 1977
- Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant propertiesPsychopharmacology, 1975
- Studies in the Classification of Affective DisordersThe British Journal of Psychiatry, 1972
- THE COURSE OF DEPRESSIVE PSYCHOSESActa Psychiatrica Scandinavica, 1968
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960